Abstract
In December 2019, the outbreak of SARS-CoV-2 started in mainland China, rapidly spreading across the globe. Currently, there is a global pandemic situation, and, with more or less success, countries such as Italy, Spain, France, and United States have initiated a first-level response. In this framework, the management of morbidly obese patients has been greatly affected. This article reviews the current hotspot issues and discusses different management strategies for patients with morbid obesity during the pandemic. The aim of this communication is to provide advice to bariatric/metabolic surgeons worldwide regarding the management and treatment of morbidly obese patients during this COVID-19 pandemic.
Get full access to this article
View all access options for this article.
